Sep 04, 2019 / 02:15PM GMT
Catherine Walden Ramsey Schulte - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Everybody, I'm Catherine Schulte. I cover Life Sciences and Diagnostics here at Baird. We're very pleased to have Bio-Techne presenting here today representing the company. So if you have a question at any time, you can email [email protected]. And I will pass it along to Chuck. Chuck?
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Great. All right, I'm on this, good. First slide, there's our new tagline, so Where Science Intersects Innovation. If you guys have ever worked on a tagline, it's harder than it sounds. I'd say dozens of hours of conflict within the team, but I like this one, finally. I think marketing finally nailed it. So -- and we're a lot about science, and we think we're a lot about innovation. And we've certainly been growing and there's a lot to talk about, so. Next slide. Guess I could do it. So we're -- we were up as high as $8 billion, it's been a tough market the last few weeks. But we're up to
Bio-Techne Corp at Robert W Baird Global Healthcare Conference Transcript
Sep 04, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers